Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Erik Washburn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 19 Article
-
Metastases to the gallbladder: Challenges of clinical and frozen section diagnosis
Barr, T., Washburn, E., Chen, G. & Hu, X., Feb 2026, In: Annals of Diagnostic Pathology. 80, 152568.Research output: Contribution to journal › Article › peer-review
-
Rare case of fatal accelerated/blast-phase myeloproliferative neoplasm arising from essential thrombocythemia
Fye, N., Malik, S., Washburn, E. & Jackson, C., Mar 2026, In: Human Pathology Reports. 43, 300825.Research output: Contribution to journal › Article › peer-review
Open Access -
Case of class II lupus nephritis with nephrotic features in the context of belimumab: Intersecting clinical challenge with academic initiative to emphasize social barriers in care
Cho, A., Shoemaker, J., Matarneh, A., Sardar, S., Mohan, P., Washburn, E., Karasinski, A., Kaur, G. & Ghahramani, N., Jan 1 2025, In: SAGE Open Medical Case Reports. 13, 2050313X251336061.Research output: Contribution to journal › Article › peer-review
Open Access -
Low mitotic count may affect the prognosis of uterine leiomyosarcoma: A report of two cases
Cho, C., Marshall, C., Washburn, E., Podczaski, E., Sorosky, J. & Bruce, S., Jun 2025, In: Gynecologic Oncology Reports. 59, 101766.Research output: Contribution to journal › Article › peer-review
Open Access -
Mantle cell lymphoma transformation to CD19-negative classic Hodgkin lymphoma as a novel mechanism of escape from CD19 chimeric antigen receptor T cell therapy
Yu, Y., Bayerl, M., Mineishi, S. & Washburn, E., Dec 2025, In: Journal of Hematopathology. 18, 1, 59.Research output: Contribution to journal › Article › peer-review